Jay Bhattacharya has spent years railing against the National Institutes of Health. What happens when he runs it?
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
The move comes two days after 25% tariffs on nearly all goods from the two countries took effect. The exemptions apply to about half of all imports from Mexico and 38% of goods from Canada and will ...
FDA nominee Martin Makary was asked about abortion drugs, vaccine panels during a Senate hearing on his bid to lead the ...
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
The John Hopkins surgeon followed the lead of Robert F. Kennedy Jr. and Jay Bhattacharya in dodging sensitive questions around federal layoffs and agency policy plans.
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
“The menopause transition specifically might be an important key to help us unlock the biology of Alzheimer’s disease, and ...
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...